These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
19 related articles for article (PubMed ID: 21258965)
1. Moderate alcohol consumption and lipoprotein subfractions: a systematic review of intervention and observational studies. Wilkens TL; Tranæs K; Eriksen JN; Dragsted LO Nutr Rev; 2022 Apr; 80(5):1311-1339. PubMed ID: 34957513 [TBL] [Abstract][Full Text] [Related]
2. Relationship between internal and external factors and the activity of PON1. Del Carmen Xotlanihua-Gervacio M; Herrera-Moreno JF; Medina-Díaz IM; Bernal-Hernández YY; Rothenberg SJ; Barrón-Vivanco BS; Rojas-García AE Environ Sci Pollut Res Int; 2019 Aug; 26(24):24946-24957. PubMed ID: 31243662 [TBL] [Abstract][Full Text] [Related]
3. PON-1 Activity and Plasma 8-Isoprostane Concentration in Patients with Angiographically Proven Coronary Artery Disease. Kuchta A; Strzelecki A; Ćwiklińska A; Totoń M; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Gliwińska A; Dąbkowski K; Jankowski M Oxid Med Cell Longev; 2015; 2015():5136937. PubMed ID: 26697134 [TBL] [Abstract][Full Text] [Related]
4. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke. Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578 [TBL] [Abstract][Full Text] [Related]
6. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects. Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308 [TBL] [Abstract][Full Text] [Related]